-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
September 01, 2011 - A single study with a
small sample size indicated no difference in
withdrawals due to adverse events … Evidence for ECT compared with rTMS indicated
higher rates of overall withdrawals in the ECT
compared … As indicated by the
review, nearly no evidence exists on how the
effectiveness of nonpharmacologic treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
January 01, 2013 - Considerations
Define exposure (treatments) of interest at start of followup Use an active comparator (indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medicare-utilization-seniors_research.pdf
June 01, 2012 - obstructive
pulmonary disease (COPD), depression, diabetes, and ischemic heart
disease.6 Cancer is indicated … conditions occurred in the initial six months of
Medicare eligibility, the chronic condition flag is indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
October 05, 2010 - Outcome tools chart: Scaling column: not all scales have
indicated the Range of the scale (Ex: SST is … In addition, for each scale, we have specified the
number of items, the overall scale and indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: April 06, 2010
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness and Safety of Oral Diabetes Medications for Adu…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
May 19, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 19, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Efficacy and Comparative Effectiveness of Off-Label Use of Atypical
Antipsychotics – Update
I. Background and Objectives for the Sys…
-
effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1412.pdf
December 01, 2014 - updates of recent data to experts and obtained new comments; experts commenting on this
intervention indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
July 01, 2017 - Dietary Marine Oils and Combined Marine Oil Supplements
�� Some evidence based on observational studies indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - uterine-fibroids-protocol-160301
Source: www.effectivehealthcare.ahrq.gov
Published online: March 1, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Management of Uter ine Fibroids
I. Background and Objectives for the Systematic Review
Topic background
Most women will dev…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - three of the GEP assays:
ColoPrint® Colon Cancer Recurrence Assay and the OncoDefender-CRC assay, indicated … available within 7 to 10 days following receipt of the tumor sample and Oncotype DX® Colon
Cancer assay indicated … If so, the predictive assay would be used if the
prognostic result indicated high risk of recurrence … Input from Key Informants indicated that currently there is little use of GEP assays in the
clinical … Input from Key Informants indicated that current standard of care for stage II patients does
not include
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_executive.pdf
April 01, 2012 - Ratios of 1 indicated that the tests likely do not provide
accurate UI diagnosis. … Individual RCTs indicated greater continence
and improvement in UI with vaginal estrogen formulations … Individual RCTs
indicated no difference in adverse effects and treatment
discontinuation with active … Studies indicated
no consistently greater benefits for continence or
improvement of UI with continence … Indirect comparison indicated the comparable effectiveness
of nonpharmacological treatments on continence
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
January 01, 2024 - Executive summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2024 Update
Comparative Effectiveness Review
Number 250
Living Systematic Review on Cannabis
and Other Plant-Based Treatments for
Chronic Pain: 2024 Update
Exec…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-executive-summary.pdf
February 01, 2025 - Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces
Systematic Review
M
ental Health and Occupational Stress in
the Emergency Medical Services and 911
Workforces
Executive Summary
Main Points
• No study reported o…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-194-disposition-comments-inhaled-corticosteroids.pdf
March 19, 2018 - therapeutic options (“Table 1: Included
pharmacologic classes and representative drug
moieties” as indicated … subset is that the baseline dosing for
BUD/Form was 80mcg/4.5mcg daily at night a
dose that is not indicated … the only thing that can be concluded from
this study is that once daily dosing of a drug that
is indicated … This should be
indicated more clearly, and if CI, a comma rather
than “to” should be used (e.g., (0.46
-
effectivehealthcare.ahrq.gov/sites/default/files/s13.pdf
October 01, 2007 - ORIGINAL ARTICLE
Methodologic Challenges to Studying Patient Safety and
Comparative Effectiveness
Brian L. Strom MD, MPH
Abstract: Studies of patient safety and comparative effectiveness
entail unique methodologic challenges. These studies may be sus-
ceptible to systematic error, including selection bias, exposure
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
August 22, 2008 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: January 22, 2010 1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Effectiveness of Recombinant Human Growth
Hormone in the Treatment of Cystic Fibrosis…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy_executive.pdf
January 01, 2017 - experience a harm, primarily post-tonsillectomy
hemorrhage (PTH), with the surgery; and 3) if surgery
is indicated
-
effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_2012-12-10.pdf
January 01, 2012 - We present two summaries on three topics (indicated by an
asterisk) that emerged as higher impact potential … United States in April
2012.
14
According to the agent’s prescribing information, florbetapir is indicated … National Institute on Aging, currently available pharmacotherapies
indicated for use in patients with
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - We present summaries on
two topics (indicated below by an asterisk) that emerged as having high-impact … The system is available in Europe, and one report indicated
that hospitals there pay about $60,000 … One report (CNN, April 2013) indicated that hospitals in Europe pay about $60,000 for each
machine.33
-
effectivehealthcare.ahrq.gov/products/cancer-end-of-life-measures-framework/research